Lemonaid Health vs MEDVi: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

48 providers verified independently·Independent research·How we rank →

MEDVi beats Lemonaid Health overall, scoring 7.7/10 vs 7.2/10. Lemonaid Health is more affordable at $248/mo vs $299/mo. Choose Lemonaid Health for users who want a flexible membership with broad medication o. Choose MEDVi for users who want a low entry price with oral and injectable co.

A side-by-side comparison of Lemonaid Health and MEDVi covering pricing, scores, medication types, insurance, and more to help you decide.

Lemonaid Health

#43 of 48

7.2/10

Established telehealth platform (acquired by 23andMe) restructured in 2026: $49/mo Weight Loss Membership + medication billed separately. Menu now includes compounded sema and tirz, compounded microdoses ($199), and brand-name Zepbound via LillyDirect ($299-449).

Visit Lemonaid Health

Higher Rated

MEDVi

#22 of 48

7.7/10

MEDVi is a compounded GLP-1 telehealth platform offering both oral tablets and injectable semaglutide and tirzepatide, with micro-dosing options for side-effect-sensitive patients. $179/mo entry pricing, free shipping, and a streamlined intake — one of the broader compounded mixes among independent telehealth providers in 2026.

Visit MEDVi

Feature	Lemonaid Health	MEDVi
Our Score	7.2/10	7.7/10
Starting Price	$248/mo	$299/mo
Medication Type	Both	Both
Insurance Accepted	No	No
Best For	Users who want a flexible membership with broad medication options — $49/mo platform fee + compounded ($199), microdose ($199), or brand-name Zepbound via LillyDirect ($299-449)	Users who want a low entry price with oral and injectable compounded options
Ranking	#43	#22

Pros & Cons Compared

Lemonaid Health

Pros

+2026 restructure — $49/mo Weight Loss Membership (replaces the old $25/visit model)
+6-month plan discount — compounded tirzepatide drops to $229/mo on a 6-month commitment
+Wide medication menu: compounded sema, compounded tirz, compounded microdoses ($199), brand-name Zepbound via LillyDirect ($299-449), and metformin
+Established since 2013 with physician-only prescribing and rigorous intake

Cons

−Membership and medication billed separately — the $49/mo number is just the membership, not all-in
−Brand-name Wegovy ($1,599) and Ozempic ($1,199) cash prices are high — read as access, not value
−Best compounded pricing requires a 6-month commitment
−The 23andMe acquisition created some uncertainty about the platform's long-term focus

MEDVi

Pros

+One of the few compounded providers offering both oral tablets and injectable semaglutide
+Micro-dosing options available — can start at sub-standard doses for patients concerned about side effects
+Sleek onboarding experience with clear progress tracking through their patient portal
+$179/mo is competitive for a platform with both oral and injectable compounded formulations

Cons

−Compounded medications only — no path to brand-name Wegovy or Zepbound through their platform
−No insurance accepted, and oral compounded semaglutide has less clinical data than injectable forms

Our Verdict

MEDVi edges out Lemonaid Health with a score of 7.7/10 vs 7.2/10. If budget is your priority, Lemonaid Health starts at $248/mo compared to MEDVi's $299/mo. Choose Lemonaid Health if you want: users who want a flexible membership with broad medication options — $49/mo platform fee + compounded ($199), microdose ($199), or brand-name zepbound via lillydirect ($299-449). Choose MEDVi if you want: users who want a low entry price with oral and injectable compounded options.

Still undecided? Editor's #1 Overall Pick

Embody

$299/mo · 7.3/10 · Compounded

If neither Lemonaid Health nor MEDVi feels like the right fit, our overall #1 pick across all 48 GLP-1 telehealth providers is Embody — strongest balance of clinical oversight, transparent pricing, and verified availability.

Visit Embody→Read our full Embody review